LifeFoundry Helps Biotech Companies with R&D Automation
In Illinois, new company, LifeFoundry, is utilizing synthetic biology and robotics to conduct research and development for biotech companies. LifeFoundry, which is part of...
No More “Accidents” when You Sneeze – New Biomaterial Implant Helps Women with Urinary...
In India, two companies, Urogyn B.V. and Leader Biomedical, are joining forces to help bring to market a new product that can help women...
American Process and MYBiomass Collaborate on Malaysia Oil Palm Biomaterials Project
In Malaysia, MYBiomass Sdn. Bhd. and Atlanta, Georgia based American Process Inc. are working together on a nanocellulose production project using oil palm empty...
Researchers Develop Tiny Implantable Biomaterial Medical Device that Runs with No Power Source
In New York, Columbia University Engineering researchers created tiny robotic type machines from biomaterials that can be implanted in the body for biomedical purposes....
Blame Biochemicals and Brain for Binge Eating After Boatload of Beers
In the United Kingdom, researchers at the Francis Crick Institute in London have found the scientific reason why you get hungry when drinking alcohol....
The Debate Continues – Is Glyphosate Dangerous to Our Health? Latest Study Says Yes,...
In the United Kingdom, researchers published a paper saying Monsanto’s controversial ingredient in Roundup, glyphosate, affects liver function even from ultra-low dose exposure. The...
Swedish researchers advance spider silk
In Sweden, researchers have addressed two of the challenges inherent to synthetically producing spider silk: “clumping” that reduces the amount of silk available for...
Stora Enso Sells Subsidiary, Formeca, to Amitec
In Finland, renewable biomaterial packaging and construction company Stora Enso is selling its subsidiary that focuses on automated packaging machinery, Formeca, to Amitec also...
New Chief Scientific Officer for Xenetic Biosciences
In Massachusetts, Xenetic Biosciences, Inc. has a new Chief Scientific Officer, Curtis A. Lockshin. Lockshin’s experience with research and development in the biopharmaceutical industry...
He Says, She Says –PixarBio and Invivo Therapuetics Send Mixed Messages About Buy-Out
In Massachusetts, PixarBio said they offered Invivo Therapeutics $77 million in a take-over bid, but Invivo Therapeutics said that’s news to them. After Invivo...